Randomized trial of immunosuppressive regimens in renal transplantation

Journal of the American Society of Nephrology

Volumn 22, Issue 9, 2011, Pages 1758-1768

  Guerra, Giselle ^a,b   Ciancio, Gaetano ^a,b   Gaynor, Jeffrey J ^a,b   Zarak, Alberto ^a,b   Brown, Randolph ^a,b   Hanson, Lois ^a,b   Sageshima, Junichiro ^a,b   Roth, David ^b   Chen, Linda ^a,b   Kupin, Warren ^b   Tueros, Lissett ^a,b   Ruiz, Phillip ^a,b   Livingstone, Alan S ^a,b   Burke III, George W ^b  

^a University of Miami Leonard M Miller School of Medicine   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT REFUSAL; VIRUS INFECTION;

EID: 80052317076     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011010006     Document Type: Article

References (29)

1. Meier-Kriesche H.U., Li S., Gruessner R.W., Fung J.J., Bustami R.T., Barr M.L., Leichtman A.B.: Immunosuppression: Evolution in practice and trends, 1994-2004. Am J Transplant 6: 1111-1131, 2006
2. Doyle A.M., Lechler R.I., Turka L.A.: Organ transplantation: Halfway through the first century. JASN 15: 2965-2971, 2004 (Pubitemid 39578827)
3. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., Chapman J.R.: The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326-2333, 2003 (Pubitemid 37509740)
4. Kaplan B., Meier-Kriesche H.U.: Renal transplantation: A half century of success and the long road ahead. JASN 15: 3270-3271, 2004 (Pubitemid 39578861)
5. MacDonald A.S.: RAPAMUNE Global Study Group: A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/ cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 71: 271-280, 2001
6. Keunecke C., Rothenpieler U., Zanker B., Schneeberger H., Illner W.D., Theodorakis J., Stangl M., Land W.: Mycophenolate mofetil monotherapy: An example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidneytransplanted patients. Transplant Proc 32: 6S-8S, 2000
7. Meier-Kriesche H.U., Steffen B.J., Hochberg A.M., Gordon R.D., Liebman M.N., Morris J.A., Kaplan B.: Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection. Am J Transplant 3: 68-73, 2003 (Pubitemid 36306826)
8. Ciancio G., Burke G.W., Suzart K., Roth D., Kupin W., Rosen A., Olsen L., Esquenazi V., Miller J.: Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients. Transplantation 73: 1100-1106, 2002 (Pubitemid 34415442)
9. European Mycophenolate Mofetil Cooperative Study Group: Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation 68: 391-396, 1999
10. Mendez R., Gonwa T., Yang H.C., Weinstein S., Jensik S, and Steinberg S for the Prograf Study Group: A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year. Transplantation 80: 303-309, 2005
11. Ojo A.O., Meier-Kriesche H.U., Hanson J.A., Leichtman A.B., Cibrik D., Magee J.C., Wolfe R.A., Agodoa L.Y., Kaplan B.: Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 69: 2405-2409, 2000 (Pubitemid 30409012)
12. Gregory C.R., Huang X., Pratt R.E., Dzau V.J., Shorthouse R., Billingham M.E., Morris R.E.: Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 59: 655-661, 1995
13. Sehgal S.N.: Sirolimus: Its discovery, biological properties, and mechanism of action. Transplant Proc 35: 7S-14S, 2003
14. Humar A., Hassoun A., Kandaswamy R., Payne W.D., Sutherland D.E., Matas A.J.: Immunologic factors: The major risk for decreased longterm renal allograft survival. Transplantation 68: 1842-1846, 1999 (Pubitemid 30027334)
15. Ciancio G., Burke G.W., Gaynor J.J., Mattiazzi A., Roth D., Kupin W., Nicolas M., Ruiz P., Rosen A., Miller J.: A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. Transplantation 77: 244-251, 2004 (Pubitemid 38155754)
16. Ciancio G., Burke G.W., Gaynor J.J., Mattiazzi A., Roth D., Kupin W., Nicolas M., Ruiz P., Rosen A., Miller J.: A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. Transplantation 77: 252-258, 2004 (Pubitemid 38155755)
17. Ciancio G., Burke G.W., Gaynor J.J., Ruiz P., Roth D., Kupin W., Rosen A., Miller J.: A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate versus cyclosporine/sirolimus in renal transplantation: Three-year analysis. Transplantation 81: 845-852, 2006
18. Mendez R., Gonwa T., Yang H.C., Weinstein S., Jensik S., Steinberg S., Prograf Study Group: A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year. Transplantation 80: 303-309, 2005 (Pubitemid 41129957)
19. Gonwa T., Mendez R., Yang H.C., Weinstein S., Jensik S, and Steinberg S for the Prograf Study Group: Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 6 months. Transplantation 75: 1213-1220, 2003
20. Gallon L., Perico N., Dimitrov B.D., Winoto J., Remuzzi G., Leventhal J., Gaspari F., Kaufman D.: Long-term renal allograft function on a tacrolimus- based, prednisone-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant 6: 1617-1623, 2006 (Pubitemid 43945801)
21. Sampaio E.L., Pinheiro-Machado P.G., Garcia R., Felipe C.R., Park S.I., Casarini D.E., Moreira S., Franco M.F., Tedesco-Silva H. Jr, Medina- Pestana JO: Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen. Clin Transplant 22: 141-149, 2008 (Pubitemid 351420007)
22. Kumar M.S.A., Saeed M.I., Ranganna K., Malat G., Sustento-Rodica N., Kumar A.M., Meyers W.C.: Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: Five-year outcomes. Transpl Immunol 20: 32-42, 2008
23. Meier-Kriesche H.U., Schold J.D., Srinivas T.R., Howard R.J., Fujita S., Kaplan B.: Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 5: 2273-2280, 2005 (Pubitemid 41648476)
24. Meier-Kriesche H.U., Chu A.H., David K.M., Chi-Burris K., Steffen B.J.: Switching immunosuppression medications after renal transplantation - A common practice. Nephrol Dial Transplant 21: 2256-2262, 2006 (Pubitemid 44295053)
25. Ekberg H., Tedesco-Silva H., Demirbas A., Vítko S., Nashan B., Gürkan A., Margreiter R., Hugo C., Grinyó J.M., Frei U., Vanrenterghem Y., Daloze P., Halloran P.F.: ELITE-Symphony Study: Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357: 2562-2575, 2007 (Pubitemid 350294223)
26. Ekberg H., Bernasconi C., Tedesco-Silva H., Vítko S., Hugo C., Demirbas A., Acevedo R.R., Grinyó J., Frei U., Vanrenterghem Y., Daloze P., Halloran P.: Calcineurin inhibitor minimization in the Symphony Study: Observational results 3 years after transplantation. Am J Transplant 9: 1876-1885, 2009
27. Srinivas T.R., Schold J.D., Guerra G., Eagan A., Bucci C.M., Meier-Kriesche H.U.: Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Am J Transplant 7: 586-594, 2007 (Pubitemid 46376441)
28. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D.: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999 (Pubitemid 29135798)
29. Solez K., Colvin R.B., Racusen L.C., Sis B., Halloran P.F., Birk P.E., Campbell P.M., Cascalho M., Collins A.B., Demetris A.J., Drachenberg C.B., Gibson I.W., Grimm P.C., Haas M., Lerut E., Liapis H., Mannon R.B., Marcus P.B., Mengel M., Mihatsch M.J., Nankivell B.J., Nickeleit V., Papadimitriou J.C., Platt J.L., Randhawa P., Roberts I., Salinas-Madriga L., Salomon D.R., Seron D., Sheaff M., Weening J.J.: Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 7: 518-526, 2007 (Pubitemid 46376465)